120 related articles for article (PubMed ID: 36715999)
1. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma.
Demedis J; Scarbro S; Suresh K; Maloney K; Forlenza GP
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e154-e160. PubMed ID: 36715999
[TBL] [Abstract][Full Text] [Related]
2. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
5. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.
Gatzioura I; Papakonstantinou E; Dimitriadou M; Kourti M; Sidi V; Triantafyllou P; Koliouskas D; Christoforidis A
Pediatr Blood Cancer; 2016 Jul; 63(7):1181-4. PubMed ID: 27062362
[TBL] [Abstract][Full Text] [Related]
6. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H; Imamura T; Saito AM; Takahashi Y; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Endo M; Hori H; Suzuki N; Kosaka Y; Kato K; Yumura-Yagi K; Hara J; Oda M; Sato A; Horibe K;
PLoS One; 2015; 10(8):e0136428. PubMed ID: 26317422
[TBL] [Abstract][Full Text] [Related]
7. Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.
Roberson JR; Spraker HL; Shelso J; Zhou Y; Inaba H; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Howard SC
Leukemia; 2009 Feb; 23(2):245-50. PubMed ID: 18923438
[TBL] [Abstract][Full Text] [Related]
8. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs.
McCormick MC; Sharp E; Kalpatthi R; Zullo J; Gurtunca N; Zhang J; Krafty R; Raman S
Pediatr Blood Cancer; 2020 Sep; 67(9):e28475. PubMed ID: 32589365
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of glycated hemoglobin and fructosamine in the long-term glycemic control of children with acute lymphoblastic leukemia.
Yetgin S; Yalçin SS; Ozbek N
Acta Paediatr Jpn; 1998 Feb; 40(1):52-6. PubMed ID: 9583201
[TBL] [Abstract][Full Text] [Related]
11. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
J Pediatr; 2009 Jul; 155(1):73-8. PubMed ID: 19394046
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Hyperglycemia During Chemotherapy for Acute Lymphoblastic Leukemia Among Taiwanese Children.
Tsai MC; Huang HH; Chou YY; Cheng CN; Chen JS; Lin SJ
Pediatr Neonatol; 2015 Oct; 56(5):339-45. PubMed ID: 26300018
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia.
Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
Pediatr Blood Cancer; 2008 Sep; 51(3):387-92. PubMed ID: 18523991
[TBL] [Abstract][Full Text] [Related]
15. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.
Vu K; Busaidy N; Cabanillas ME; Konopleva M; Faderl S; Thomas DA; O'Brien S; Broglio K; Ensor J; Escalante C; Andreeff M; Kantarjian H; Lavis V; Yeung SC
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):355-62. PubMed ID: 22658895
[TBL] [Abstract][Full Text] [Related]
17. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of weight loss during induction therapy for childhood acute lymphoblastic leukemia.
Hill R; Hamby T; Johnson D; Boren C; Downs H; Ray A
Nutrition; 2021 Jan; 81():110937. PubMed ID: 33045486
[TBL] [Abstract][Full Text] [Related]
19. Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.
Wintergerst KA; Foster MB; Sullivan JE; Woods CR
J Diabetes Sci Technol; 2012 Jan; 6(1):5-14. PubMed ID: 22401317
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL).
Aisyi M; Andriastuti M; Kurniati N
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2619-2624. PubMed ID: 31554355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
